Lazard Asset Management
CDMO

Lazard Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Lazard Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-559,001
Closed -$6.36M – 2589
2024
Q3 		$6.36M Buy
+559,001
New +$5.61M 0.01% 572
2024
Q1 		– Sell
-54,000
Closed -$351K – 2437
2023
Q4 		$351K Buy
+54,000
New +$348K ﹤0.01% 1212
2023
Q3 		– Sell
-160,936
Closed -$2.25M – 2517
2023
Q2 		$2.25M Buy
160,936
+33,928
+27% +$578K ﹤0.01% 869
2023
Q1 		$2.38M Sell
127,008
-77,656
-38% -$1.28M ﹤0.01% 881
2022
Q4 		$2.82M Buy
204,664
+171,593
+519% +$2.63M ﹤0.01% 843
2022
Q3 		$632K Buy
33,071
+1,237
+4% +$22.5K ﹤0.01% 1061
2022
Q2 		$485K Sell
31,834
-3,039
-9% -$44.9K ﹤0.01% 1124
2022
Q1 		$710K Sell
34,873
-1,444
-4% -$29.4K ﹤0.01% 1050
2021
Q4 		$1.06M Buy
36,317
+31,732
+692% +$908K ﹤0.01% 995
2021
Q3 		$98K Sell
4,585
-16
-0.3% -$386 ﹤0.01% 1432
2021
Q2 		$118K Buy
4,601
+747
+19% +$16K ﹤0.01% 1304
2021
Q1 		$70K Buy
+3,854
New +$64K ﹤0.01% 1304
2020
Q4 		– Sell
-8,419
Closed -$64K – 2017
2020
Q3 		$64K Buy
+8,419
New +$63.8K ﹤0.01% 1115
2020
Q1 		– Sell
-600
Closed -$4K – 1785
2019
Q4 		$4K Buy
+600
New +$3.5K ﹤0.01% 1445

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Lazard Asset Management's CDMO Position: Q4 2024 in Review

Lazard Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 559,001 shares — an estimated $6.36M sold.

Lazard Asset Management first reported a position in CDMO in Q4 2019 and held it in 14 quarters. The position peaked at $6.36M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Lazard Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 559,001 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $6.36M.
  • Lazard Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
  • Lazard Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $6.36M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.